WHO ICTRP trial
Phase 2, open-label, multicentre, single-arm study to evaluate the activity of…
CTIS2024-518892-72-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-518892-72-00 |
|---|---|
| Public title | Phase 2, open-label, multicentre, single-arm study to evaluate the activity of the combination of EGFR inhibitors and c-MET inhibitors in patients with platinum-resistant head and neck squamous cell carcinoma after relapse to immunotherapy. |
| Scientific title | Phase 2, open-label, multicentre, single-arm study to evaluate the activity of the combination of EGFR inhibitors and c-MET inhibitors in patients with platinum-resistant head and neck squamous cell carcinoma after relapse to immunotherapy. - TEPMEETCET |
| Primary sponsor | Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia |
| Secondary sponsors | Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Italy |
| Conditions | Head and neck cancer MedDRA version: 21.1Level: PTClassification code: 10067821Term: Head and neck cancer Class: 100000004864;Therapeutic area: Diseases [C] - Neoplasms [C04] |
| Interventions | Product Name: CETUXIMAB, Product Code:SUB01178MIG, Pharmaceutical Form: SOLUTION FOR INFUSION, Other descriptive name: , Strength: , Product Name: TEPOTINIB, Product Code:SUB189535, Pharmaceutical Form: FILM-COATED TABLET, Other descriptive… |
| Registration date | Nov 29, 2024 |
| Target size | 30 |
| Secondary IDs | 2022-002841-17 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: